Login / Signup

Long-term drug survival of secukinumab in real life in the era of novel biologics: a 5-year, retrospective study, including difficult-to-treat areas.

Elena SotiriouKaterina BakirtziE VakirlisIlias PapadimitriouP EftychidouM TrifonaAimillios LallasDemetrios Ioannides
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Keyphrases
  • ankylosing spondylitis
  • free survival
  • adverse drug
  • rheumatoid arthritis